Status:
RECRUITING
A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou
Lead Sponsor:
Singlera Genomics Inc.
Collaborating Sponsors:
Northern Jiangsu People's Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
40-74 years
Brief Summary
This is a cross-sectional cohort study based on community population jointly developed by Northern Jiangsu People's Hospital and Shanghai Kunyuan Biological Technology Co., LTD. This study will verify...
Detailed Description
The study is expected to complete baseline examinations of 80,000 subjects within 1 year. Community members who sign informed consent forms will complete the Colorectal cancer Risk Factor Assessment Q...
Eligibility Criteria
Inclusion
- 1\) Permanent resident population of Yangzhou; 2) Chronological age: 40\~74 years, including critical value (refer to birth date of id card); 3) Have full capacity of conduct; 4) After enrollment, they could voluntarily cooperate to complete the Colorectal cancer Risk Factor Assessment Questionnaire and accept telephone follow-up; 5) Agree to timely feed back the information related to tumor diagnosis to the investigator during the study process; 6) Willing and able to sign informed consent.
Exclusion
- 1\) History of colorectal cancer and other malignant tumors; 2) previous colorectal resection; 3) are receiving any cancer-related treatment; 4) Those who have received major surgical treatment such as blood transfusion and transplantation within 3 months; 5) Participate in other interventional clinical investigators within 3 months; 6) Pregnant or lactating women; 7) Patients with autoimmune diseases, genetic diseases, mental diseases/disabilities and other diseases considered unsuitable for the study by the researcher; 8) Poor compliance, unable to complete the study according to the judgment of the researcher.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
80000 Patients enrolled
Trial Details
Trial ID
NCT05336539
Start Date
April 1 2022
End Date
April 1 2027
Last Update
August 29 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China, 201299
2
Yangzhou First People's Hospital
Yangzhou, Jiangsu, China, 225007